heart attack

Do antidepressants take more lives than they save?An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.
Beta blockers not needed for heart attack survivors taking these drugsA new study has shocking results about beta blocker use in heart-attack survivors.
Blockbuster diabetes drug earns heart indication
Blockbuster diabetes drug earns heart indicationA top-selling diabetes drug has gained a cardiovascular indication from FDA.
Shingles associated with increased risk of stroke, heart attackPatients who have a history of herpes zoster may have an increased risk of heart attack or stroke, according to findings published in a research letter.
Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.
Diabetes increases risk of heart attack by halfUK study: Diabetes increases risk of heart attack death. Here are the surprising details.
FDA denies claims for Zetia, VytorinFDA declined to approve Merck’s claim that its cholesterol-lowering drugs Zetia and Vytorin reduce the risk of heart attacks and strokes in patients with coronary heart disease.
FDA expands Brilinta approval for long-term use in patients with heart attack historyFDA has expanded approval for ticagrelor (Brilinta, AstraZeneca) to include long-term use in patients with a history of heart attack.
Diabetes drug may reduce stroke, CV deathsJardiance is the first diabetes drug that has also been shown to lower strokes, heart attacks and cardiovascular deaths, according to a new study.
FDA warns of early MI, stroke risk with non-aspirin NSAIDsMI and stroke risk can rise just weeks after NSAID use commences. Labels will be updated to reflect this.